Translational Psychiatry open-access icon

Journal Title

  • Translational Psychiatry

ISSN

  • P 2158-3188 | 2158-3188

Publisher

  • Nature Publishing Group
  • Springer Nature

Listed on(Coverage)

JCR2013-2019
SJR2012-2019
CiteScore2012-2019
SCIE2012-2021
CC2016-2021
SCOPUS2017-2020
MEDLINE2016-2021
DOAJ2017-2021
EMBASE2016-2020

OA Info.

OAopen-access icon

based on the information

  • 2017;2018;2019;2020;2021;
Keywordsneuroscience, translational psychiatry
Review ProcessBlind peer review
Journal info. pages
LicencesCC BY
CopyrightsNo
DOAJ Coverage
  • Added on Date : 2012-06-11T13:51:36Z
Subject(s)Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry

Active

  • Active

    based on the information

    • SCOPUS:2020-10

Country

  • ENGLAND

Aime & Scopes

  • Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod's discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.

Article List

1 - 5 out of 5 results.

1

BROWSE